These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15044465)

  • 21. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.
    Wang SE; Xiang B; Zent R; Quaranta V; Pozzi A; Arteaga CL
    Cancer Res; 2009 Jan; 69(2):475-82. PubMed ID: 19147560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
    Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
    Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin.
    Kim HP; Kim TY; Lee MS; Jong HS; Kim TY; Lee JW; Bang YJ
    Biochim Biophys Acta; 2005 Mar; 1743(1-2):151-61. PubMed ID: 15777850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
    Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
    Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
    Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC
    Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.
    Lebrin F; Goumans MJ; Jonker L; Carvalho RL; Valdimarsdottir G; Thorikay M; Mummery C; Arthur HM; ten Dijke P
    EMBO J; 2004 Oct; 23(20):4018-28. PubMed ID: 15385967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators.
    Wang SE; Yu Y; Criswell TL; Debusk LM; Lin PC; Zent R; Johnson DH; Ren X; Arteaga CL
    Oncogene; 2010 Jun; 29(23):3335-48. PubMed ID: 20383197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
    Bourguignon LY; Singleton PA; Zhu H; Zhou B
    J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer.
    Dokmanovic M; Hirsch DS; Shen Y; Wu WJ
    Mol Cancer Ther; 2009 Jun; 8(6):1557-69. PubMed ID: 19509242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential activation of Smads in HeLa and SiHa cells that differ in their response to transforming growth factor-beta.
    Maliekal TT; Anto RJ; Karunagaran D
    J Biol Chem; 2004 Aug; 279(35):36287-92. PubMed ID: 15192088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential sensitivities of trastuzumab (Herceptin)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors.
    Chan CT; Metz MZ; Kane SE
    Breast Cancer Res Treat; 2005 May; 91(2):187-201. PubMed ID: 15868447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function.
    Feldman G; Kiely B; Martin N; Ryan G; McMorrow T; Ryan MP
    J Am Soc Nephrol; 2007 Jun; 18(6):1662-71. PubMed ID: 17460148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
    J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXO1A is a target for HER2-overexpressing breast tumors.
    Wu Y; Shang X; Sarkissyan M; Slamon D; Vadgama JV
    Cancer Res; 2010 Jul; 70(13):5475-85. PubMed ID: 20551062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation.
    Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D
    J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades.
    Schiemann WP; Blobe GC; Kalume DE; Pandey A; Lodish HF
    J Biol Chem; 2002 Jul; 277(30):27367-77. PubMed ID: 12021267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.